Poster Session D - Tuesday Morning
Tanisha Kalra, MD
SUNY Downstate Health Science University
New York, NY
TEST | ON ADMISSION | PEAK VALUE | ON DISCHARGE(POST-CANAKINUMAB) |
WBC | 10,870 | 33,710 | 8210 |
AST | 91 | 625 | 40 |
ALT | 19 | 294 | 82 |
ALP | 48 | 1460 | 554 |
Total Bilirubin | 0.6 | 12.6 | 1.1 |
Direct Bilirubin | - | 8.6 | 0.6 |
GGT | - | 1136 | - |
CRP | 120 | 168 | < 5 |
ESR | 43 | 90 | 19 |
Ferritin | >40,000 | >40,000 | 518 |
Rheumatoid Factor | 12 | - | - |
ANA | Negative | - | - |
Hepatitis A IgM | Non-reactive | - | - |
Hepatitis A IgG | Reactive | - | - |
HbsAg | Non-reactive | - | - |
HbsAb | Reactive | - | - |
HbcAb | Non-reactive | - | - |
HbeAg | Non-reactive | - | - |
HbeAb IgM | Non-reactive | - | - |
HbeAb IgG | Reactive | - | - |
HBV DNA | Not detected | - | - |
Hepatitis C Antibody | Non-reactive | - | - |
Alpha-1 antitrypsin | Normal | - | - |
Ceruloplasmin | Normal | - | - |
Anti-Mitochondrial Antibody | Negative | - | - |
Anti-SMA | Negative | - | - |
Anti-LKM Antibody | Negative | - | - |